Medicinal Mushroom Biotechnology

Authors

  • Marin Berovic

  • Bojana Boh

  • Andrej Gregori

medicinal mushrooms, cultivation techniques, bioreactors

Abstract

Since most of medicinal mushrooms are rare in nature production of fungal fruiting bodies using artificial cultivation in a form of farming has been intensively established during the last 40 years. Solid state cultivation of various medicinal mushroom mycelia in various types of bioreactors, suitable for veterinary use, appears slightly in last few decades. Developing submerged technologies, using stirred tank and air lift bioreactors, are the most promising technologies for fast and large cultivation of medicinal pharmaceutically active products for human need. This potential initiates the development of new drugs and some of the most attractive over the counter human and veterinary remedies. This article is an overview of the engineering achievements in comprehensive medicinal mushroom mycelia cultivation.

Downloads

How to Cite

Medicinal Mushroom Biotechnology. (2024). Global Journal of Science Frontier Research, 24(7), 35-51. https://www.journalofscience.org/index.php/GJSFR/article/view/102879

References

S. Wasser (2010) Medicinal mushroom science: history, current status, future trends, and unsolved problems. 12, 1-16.

Shu-Ting Chang, Solomon Wasser (2012) The Role of Culinary-Medicinal Mushrooms on Human Welfare with a Pyramid Model for Human Health. 14(2), 95-134. https://doi.org/10.1615/intjmedmushr.v14.i2.10

S. Chang, S. Wasser (2018) T.; Wasser, S.P Current and future research trends in agricultural and biomedical applications of medicinal mushrooms and mushroom products (Review). 20, 11-21.

B. Boh (2013) Ganoderma lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs. 8, 255-287.

I. Zmitrovich, N. Belova, M. Balandaykin, M. Bondartseva, S. Wasser (2019) Cancer without pharmacological illusions and a niche for mycotherapy (Review). 21, 105-109.

S. Griffiths (2016) kick started. https://www.dailymail.co.uk/sciencetech/article-3472781/The-fossilised-fungus-kickstarted-life-Earth-440-million-year-old-mushroom-oldest-organism-lived-dry-land.html

Chang, J. S.T.; Buswell (1999) Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae)-A Mushrooming Medicinal Mushroom. 1, 139-146.

Sandra Baldauf, A. Roger, I. Wenk-Siefert, W. Doolittle (2000) A Kingdom-Level Phylogeny of Eukaryotes Based on Combined Protein Data. 290(5493), 972-977. https://doi.org/10.1126/science.290.5493.972

Laura Katz, Jessica Grant, Laura Parfrey, J. Burleigh (2012) Turning the Crown Upside Down: Gene Tree Parsimony Roots the Eukaryotic Tree of Life. 61(4), 653-660. https://doi.org/10.1093/sysbio/sys026

Shuting Chang, John Buswell (2023) Medicinal Mushrooms: Past, Present and Future. 1-27. https://doi.org/10.1007/10_2021_197

B. Boh Podgornik, M. Berovic (2011) Ganoderma lucidum Production of Pharmaceuticals In: Biochemistry Research Trends, Liong, M.T Ed Bioprocess Sciences and Technology. 2011, 233-268.

Jiezhong Chen, Robert Seviour (2007) Medicinal importance of fungal β-(1→3), (1→6)-glucans. 111(6), 635-652. https://doi.org/10.1016/j.mycres.2007.02.011

Mohammad-Fata Moradali, Hossein Mostafavi, Shirin Ghods, Ghorban-Ali Hedjaroude (2007) Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). 7(6), 701-724. https://doi.org/10.1016/j.intimp.2007.01.008

S. Wasser (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. 60, 258-274.

S. Jong, J. Birmingham Medicinal Benefits of the Mushroom Ganoderma.

K. Perumal (2009) Indigenous technology on organic cultivation of Reishi (Ganoderma lucidum) in India. 2009, 592-595.

K. Tasaka, M. Akagi, K. Miyoshi, M. Mio, T. Makino (1988) Anti-allergic constituents in the culture medium ofGanoderma lucidum. (I) Inhibitory effect of oleic acid on histamine release. 23(3-4), 153-156. https://doi.org/10.1007/bf02142526

K. Kino, T. Sone, J. Watanabe, A. Yamashita, H. Tsuboi, H. Miyajima, H. Tsunoo (1991) Immunomodulator, LZ-8, prevents antibodyproduction in mice, Int J Immunopharmacol. 13, 1109-1115.

Ji, Z.; Tang, Q.; Zhang, J.; Yang, Y.; Liu, Y.; Tang, Y. C.; Pan (2009) Immunomodulation of bone marrow macrophages by GLIS, a proteoglycan fraction from Ganoderma lucidum. 2009, 596-603.

L. Ye, X. Zheng, J. Zhang, Q. Tang, Y. Yang, X. Wang, J. Li, Y. Liu, Y. Pan Biochemical characterization of a proteoglycan complex from an edible mushroom Ganoderma lucidum fruiting bodies and its immunoregulatory activity.

J. Yuen, M. Gohel, C. Ng (2011) The differential immunological activities of Ganoderma lucidum on human pre-cancerous uroepithelial cells J Ethnopharmacol. 135, 711-718.

Zhang, J.; Tang, Q.; Zhou, C.; Da Silva, L.; Nguyen, D.; Reutter, H. W.; Fan (2009) Mice and inhibition of tumour growth by GLIS, a bioactive proteoglycan from Ganoderma lucidum. 2009, 547-562.

Z. Jiang, T. Jin, F. Gao, J. Liu, J. Zhong, H. Zhao (2011) Effects of Ganoderic acid Me on inhibiting multidrug resistance and inducing apoptosis in multidrug resistant colon cancer cells Proc Biochem. 46, 1307-1314.

I. Jakopovich (2009) Medicinal mushroom preparations against lung cancer Abstracts of the 5th International medicinal mushroom conference, Nantong, 5-8. 2009, 71-73.

Seung Lee, Hee Rhee (1990) Cardiovascular effects of mycelium extract of Ganoderma lucidum - inhibition of sympathetic outflow as a mechanism of its hypotensive action Chem Pharm Bull. 38(5), 1359-1364. https://doi.org/10.1248/cpb.38.1359

S. El-Mekkawy, M. Meselhy, N. Nakamura, Y. Tezuka, M. Hattori, N. Kakiuchi, K. Shimotohno, T. Kawahata, T. Otake Anti-HIV-1 and anti-HIV-1 protease substances from Ganoderma lucidum.

S. Wasser, A. Weiss, Medicinal mushrooms - G, lucidum (1997) Reishi mushroom.

Z. Lin, B. Yang, Ganoderma, Health (2019) Ganoderma and Health: Biology, Chemistry and Industry. 2019, 107-134.

Zhi-Bin Lin (2005) Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum J Pharmacol Sci. 99(2), 144-153. https://doi.org/10.1254/jphs.crj05008x

R. Russell, M. Paterson (2006) Ganoderma lucidum - A therapeutic fungal biofactory Phytochemistry. 67.

B. Boh, M. Berovic, J. Zhang, L. Zhi-Bin (2007) Berovic, M Zhang, J Zhi-Bin, L Ganoderma lucidum and its pharmaceutically active compounds In: El-Gewely MR, editor Biotechnology Annual Review. 2007, 265-301.

C. Lai, J. Hung, H. Lin, A. Yu, S. Chen, Y. Tsai (2010) C Immunomodulatory and adjuvant activities of a polysaccharide extract of Ganoderma lucidum in vivo and in vitro Vaccine. 28, 4945-4954.

J. Zhang, Q. Tang, C. Zhou, W. Jia, L. De Silva, L. Nguyen (2010) Zhou, C.; Jia, W.; De Silva, L.; Nguyen, L.D GLIS, a bioactive proteoglycan fraction from Ganoderma lucidum, displays antitumor activity by increasing both humoral and cellular immune response Life Sci. 87, 628-637.

M. Novak, V. Vetvicka (2007) β-glucans, history, and present: immunomodulatory aspects and mechanisms of action J Immunotoxicol. 5, 47-57.

Godfrey Chan, Wing Chan, Daniel Sze (2009) The effects of β-glucan on human immune and cancer cells. 2(1), 1-11. https://doi.org/10.1186/1756-8722-2-25

J. Zhe, Q. Tang, J. Zhang, Y. Yang, W. Jia, Y. Pan (2007) Immunomodulation of RAW264.7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum J Ethnopharmacol. 112, 445-450.

H. Chen, Y. Tsai, S. Lin, C. Lin, K. Khoo, C. Lin (2004) Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides Bioorg Med Chem. 12, 595-601.

M. Berovic, J. Habijanic, I. Zore, B. Wraber, D. Hodzar, B. Boh (2003) Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharides J Biotechnol. 103, 77-86.

K. Hirose, S. Muto, K. Niimura, M. Ohara, Y. Oguchi, K. Matsunaga, J. Kadochi, N. Sugita, T. Furushu, C. Yoshikumi, M. Takahashi, J. agent, Patent (1988) Antiviral agent. 63316734.

Julie Frank, Rijin Xiao, Shanggong Yu, Matthew Ferguson, Leah Hennings, Pippa Simpson, Martin Ronis, Nianbai Fang, Thomas Badger, Frank Simmen (2006) Effect of Shiitake mushroom dose on colon tumorigenesis in azoxymethane-treated male Sprague-Dawley rats Nutr Res. 26(3), 138-145. https://doi.org/10.1016/j.nutres.2006.03.001

H. Nanba, K. Kubo (1997) Effect of Maitake D-fraction on cancer prevention Ann N.Y Acad Sci. 833, 204-207.

Nachi Harada, Noriko Kodama, Hiroaki Nanba (2003) Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice Cancer Lett. 192(2), 181-187. https://doi.org/10.1016/s0304-3835(02)00716-4

N. Kodama, Y. Murata, A. Asakawa, A. Inui, M. Hayashi, N. Sakai, H. Nanba (2005) Maitake Dfraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumorbearing mice. 21, 624-629.

H. Lin, Y. She, B. Cassileth, F. Sirotnak, S. Cunningham Rundles Maitake beta-glucan MDfraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. 4.

R. Barry, G. Govindan, A. Miller (2003) Grifola extracts and methods of use thereof.

Noriko Kodama, Maho Yamada, Hiroaki Nanba (2001) Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice Jpn J Pharmacol. 87(4), 327-332. https://doi.org/10.1254/jjp.87.327

A. Mlinarič, M. Kač, F. Pohleven (2005) Screening of selected wood-damaging fungi for the HIV-1 reverse transcriptase inhibitors Acta Pharm. 55, 69-79.

V. Manohar, N. Talpur, B. Echard, S. Lieberman, H. Preuss Effects of a water-soluble extract of Maitake mushroom on circulating glucose/insulin concentrations in KK mice.

Kyungah Jung, In-Ho Kim, Daeseok Han (2004) Effect of medicinal plant extracts on forced swimming capacity in mice J Ethnopharmacol. 93(1), 75-81. https://doi.org/10.1016/j.jep.2004.03.022

Jun Bae, Gwan Sim, Dong Lee, Bum Lee, Hyeong Pyo, Tae Choe, Jong Yun (2005) Production of exopolysaccharide from mycelial culture ofGrifola frondosaand its inhibitory effect on matrix metalloproteinase-1 expression in UV-irradiated human dermal fibroblasts. 251(2), 347-354. https://doi.org/10.1016/j.femsle.2005.08.021

Q. Shen (2001) Molecular phylogenetic analysis of Grifola frondosa (Maitake) and related species and the influence of selected nutrient supplements on mushroom yield.

T. Mizuno (1995) Bioactive biomolecules of mushrooms: food function and medicinal effect of mushroom fungi. 11(1), 7-21.

T. Mizuno (1999) Bioactive Substances in Hericium erinaceus (Bull.: Fr.) Pers. (Yamabushitake), and Its Medicinal Utilization. 1, 105-120.

E. Kolotushkina, M. Moldavan, K. Voronin, G. Skibo (2003) The influence of Hericium erinaseus extract on myelination process in vitro; Fiziologichniy Zhurnal, 2003. 49(1), 38-46.

A. Erinacines (1994) Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. 35(10), 1569-1572.

H. Kawagishi, A. Shimada, K. Shizuki, H. Mori (1996) Erinacine D, a stimulator of NGF-synthesis, from the mycelia of Hericium erinaceum. 2, 51-54.

E. Erinacines (1996) Erinacines E, F, and G, stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. 37, 7399-7402.

H. Kawagishi, A. Masui, S. Tukuyama, T. Nakamura (2006) Erinacines J and K from the mycelia of Hericium erinaceum. 62, 8463-8466.

Hiromichi Kenmoku, Takeshi Sassa, Nobuo Kato (2000) Isolation of Erinacine P, a new parental metabolite of cyathanexylosides, from Hericium erinaceum and its biomimetic conversion into erinacines A and B Tetrahedron Lett. 41(22), 4389-4393. https://doi.org/10.1016/s0040-4039(00)00601-8

H. Kenmoku, T. Shimai, T. Toyomasu, N. Kato, T. Sassa Erinacine Q, a new erinacine from Hericium erinaceum and its biosynthetic route to erinacine C in the Basidiomycete.

Fangyuan Cui, Xia Gao, Jianjun Zhang, Min Liu, Chen Zhang, Nuo Xu, Huajie Zhao, Lin Lin, Meng Zhou, Le Jia (2016) Protective effects of extracellular and intracellular polysaccharides on Hepatotoxicity by Hericium erinaceus SG-02 Current Microbiol. 73(3), 379-385. https://doi.org/10.1007/s00284-016-1073-1

S. Kim, E. Moon, S. Nam, M. Friedman (2012) Hericium erinaceus mushroom extracts protect infected mice against Salmonella Typhimurium- Induced liver damage and mortality by stimulation of innate immune cells J.Agric.Food Chem. 60, 5590-5596.

Zhang, Z. Li, G. Pan, H. Pandey, A.; He, L. W.Q.; Fan (2012) Antioxidant and hepatoprotective potential of endo-polysaccharides from Hericium erinaceus grown on tofu whey Int J Biol Macromol. 51(5), 1140-1146. https://doi.org/10.1016/j.ijbiomac.2012.09.002

K. Chu, S. Ho, A. Chow (2002) Trametes versicolor: a medicinal mushroom with promising immunotherapeutic values, J Clin Pharm. 42, 976-984.

H. Dou, Y. Chang, Z. Zhang (2019) Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. 163, 361-381.

K. Cheng, P. Leung (2008) General review of polysaccharopeptides (PSP) from C. versicolor: Pharmacological and clinical studies. 6, 117-130.

T. Ng A Review of Research on the Protein- Bound Polysaccharide (Polysaccharopeptide, PSP) from the Mushroom Trametes versicolor (Basidiomycetes: Polyporaceae).

T. Hattori, N. Komatsu, S. Shichijo, K. Itoh Protein-bound polysaccharide K induced apoptosis of the human Burkitt lymphoma cell line.

C. Ho, C. Lau, C. Kim Differnetial effect of Trametes versicolor (Yunzhi) extract on cytokine production by murine lymphocytes in vitro.

Ho, C. Kim, K. C.F.; Leung (2006) Coriolus versicolor (Yunzhi) extract attenuates growth of human leukemia xenografts and induces apoptosis through the mitochondrial pathway. 16, 609-616. https://doi.org/10.3892/or.16.3.609

Harhaji, L.; ć, D. S.; Maksimović -Ivanić (2008) Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: In vitro and in vivo study. 46(5), 1825-1833. https://doi.org/10.1016/j.fct.2008.01.027

B. Sevastere, I. Prodan, R. Manalachioae (2010) Antitumor Effect of Trametes versicolor Queil Alcoholic Extract, Bulletin UASVM, Vet Med. 67(1), 263-269.

P. Kidd The use of mushroom glucans and proteoglycans in cancer treatment.

Jian Cui, Yusuf Chisti (2003) Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. 21(2), 109-122. https://doi.org/10.1016/s0734-9750(03)00002-8

Price, L. Wenner, C. D.T (2010) Role for tolllike receptor 4 in TNF-alpha secretion by murine macrophages in response to polysaccharide Krestin, a Trametes versicolor mushroom extract, Fitoterapia, 2010. 81(7), 914-919. https://doi.org/10.1016/j.fitote.2010.06.002

Zhao-Mei Wang, Xiao Peng, Kam-Len Lee, Johnny Tang, Peter Cheung, Jian-Yong Wu (2011) Structural characterisation and immunomodulatory property of an acidic polysaccharide from mycelial culture of Cordyceps sinensis fungus Cs-HK1 Food Chem. 125(2), 637-643. https://doi.org/10.1016/j.foodchem.2010.09.052

Xiaoxia Zhou, Liping Luo, Waike Dressel, Gulibahaer Shadier, Doreen Krumbiegel, Peter Schmidtke, Fred Zepp, Claudius Meyer (2008) Cordycepin is an immunoregulatory active ingredient of Cordyceps sinensis Am J Chin Med. 36(05), 967-980. https://doi.org/10.1142/s0192415x08006387

B. Lee, J. Park, J. Park, H. Shin, S. Kwon, M. Yeom, B. Sur, S. Kim, M. Kim, H. Lee, S. Yoon, D. Hahm Cordyceps militaris improves neurite outgrowth in neuro2A cells and reverses memory impairment in rats.

J. Lee, S. Hong, J. Yun, H. Myoung, M. Kim (2011) Anti-cancer effects of cordycepin on oral squamous cell carcinoma proliferation and apoptosis in vitro J Cancer Ther. 2, 224-234.

Seema Patel, Arun Goyal (2012) Recent developments in mushrooms as anti-cancer therapeutics: a review 3 Biotech. 2(1), 1-15. https://doi.org/10.1007/s13205-011-0036-2

Kai Yue, Meng Ye, Zuji Zhou, Wen Sun, Xiao Lin (2013) The genus Cordyceps: a chemical and pharmacological review J Pharm Pharmacol. 65(4), 474-493. https://doi.org/10.1111/j.2042-7158.2012.01601.x

K. Overgaard (1964) The inhibition of 5-phosphoribosyl- 1- pyrophosphate formation by Cordycepin triphosphate in extracts of Ehrlich ascites tumor cells Biochim Biophys Acta. 80, 504-507.

F. Rottman, A. Guarino (1964) The inhibition of phosphoribosyl-pyrophosphate amidotransferase activity by cordycepin mono phosphate Biochim Biophys Acta. 89, 465-472.

Sandra Holbein, Agnieszka Wengi, Laurence Decourty, Florian Freimoser, Alain Jacquier, Bernhard Dichtl (2009) Cordycepin interferes with 3′ end formation in yeast independently of its potential to terminate RNA chain elongation. 15(5), 837-849. https://doi.org/10.1261/rna.1458909

Y. Wong, A. Moon, R. Duffin, A. Barthet-Barateig, H. Meijer, M. Clemens, C. de Moor (2010) Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction J Biol Chem. 285, 2610-2621.

X. Chen, G. Wu, Z. Huang Structural analysis and antioxidant activities of polysaccharides from cultured Cordyceps militaris.

Jia Guan, Jing Zhao, Kun Feng, De-Jun Hu, Shao-Ping Li (2011) Comparison and characterization of polysaccharides from natural and cultured Cordyceps using saccharide mapping, Anal Bioanal Chem. 399(10), 3465-3474. https://doi.org/10.1007/s00216-010-4396-y

R. Russell, M. Paterson (2008) Cordyceps - A traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry. 69, 1469-1495.

Cunningham, K. Manson, W.; Spring, S. F.S.; Hutchinson (1950) Cordycepin, a Metabolic Product isolated from Cultures of Cordyceps militaris (Linn.) Link. 166, 949-954.

S. Das, M. Masuda, M. Hatashita, A. Sakurai, M. Sakakibara (2010) Effect of inoculation on production of anti-cancer drug-cordycepin in surface liquid culture using Cordyceps militaris mutant: a minor factor may greatly affect the result Indian J Biotechnol. 9, 427-430.

Shonkor Das, Mina Masuda, Akihiko Sakurai, Mikio Sakakibara (2010) Medicinal uses of the mushroom Cordyceps militaris: current state and prospects Fitoterapia. 81(8), 961-968. https://doi.org/10.1016/j.fitote.2010.07.010

B. Boh Podgornik, M. Berovic (2012) Cultivation of Ganoderma lucidum and Grifola frondosa and production of their pharmaceutical active compounds In: Petre M., Berovic, M (Eds.) Mushroom biotechnology and bioengineering. 2012, 21-84.

M. Nikšić, B. Boh Podgornik, M. Berovic (2023) Farming of Medicinal Mushrooms.

D. Royse (1996) Specialty mushrooms. In: J. Janick Ed., Progress in new crops. ASHS Press, Arlington. 1996, 464-475.

Mitchell, M. D.A.; Berovic (1998) Solid state cultivation In: Bioprocess Engineering Course, Ed. 1998, 128-167.

A. Gregori, Kretschmer, N.; Wagner, S.; Boechzelt, H.; Klinar, D.; Bauer, R.; F (2012) Influence of Olive Oil Press Cakes on Shiitake Culinary-Medicinal Mushroom, Lentinus edodes (Berk.) Singer (Higher Basidiomycetes) Fruiting Bodies Production and Effect of their Crude Polysaccharides on CCRF- CEM Cell Proliferation. 14(4), 419-424.

Arora, S.; Rani, S. R.; Ghosh (2018) Bioreactors in solid state cultivation technology: Design, applications and engineering aspects. 26, 916-34.

H. Hikino, C. Konno, Y. Mirin, T. Hayashi (1985) Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. (4), 339-40.

M. Berovic, B. Boh Podgornik Engineering aspects in production of various medicinal mushrooms biomass in submerged bioreactors.

M. Berovic, M. Popović (2018) Submerged cultivation of Ganoderma lucidum biomass in stirred tank reactor Chem Biochem Eng Quart. 32(4), 465-472. https://doi.org/10.15255/cabeq.2018.1371

V. Elisashvili (2012) Submerged Cultivation of Medicinal Mushrooms: Bioprocesses and Products (Review), Int.J.Med Mush. 14(3), 211-239.

F. Cui, Y. Li, Z. Xu, H. Xu, K. Sun, W. Tao (2006) Optimization of the medium composition for production of mycelial biomass and exo-polymer by Grifola frondosa GF9801 using response surface methodology. 10, 209-1216.

I. Zore, M. Berovic, B. Boh Podgornik, D. Hodzar, F. Pohleven (1998) Procedure for preparation of inoculum for growing of fungus Ganoderma lucidum by submersion cultivation.

D. Huang, F. Cui, Y. Li, Z. Zhang, J. Zhao, X. Han, X. Xiao, J. Qian, Q. Wu, G. Guan (2007) Nutritional Requirements for the Mycelial Biomass and Exopolymer Production by Hericium erinaceus CZ-2 Food Technol Biotechnol. 45(4), 389-395.

J. Smole (2015) Submerged cultivacition of Trametes versicolor in stirred tank bioreactor.

Jeong Kwon, Jong Lee, Won Shin, Keun Lee, Eock Hong (2009) Optimization of culture conditions and medium components for the production of mycelial biomass and exo-polysaccharides with Cordyceps militaris in liquid culture biotechnology Bioproc Engineering. 14(6), 756-762. https://doi.org/10.1007/s12257-009-0024-0

L. Fana, A. Soccol, A. Pandey, R. Soccol (2007) Effect of nutritional and environmental conditions on the production of exo-polysaccharide of Agaricus brasiliensis by submerged cultivation and its antitumor activity, LWT Food Sci Technol. 40, 30-35.

M. Lung, C. Hsieh (2011) Antioxidant property and production of extracellular polysaccharide from Armillaria mellea in submerged cultures: effect of culture aeration rate Eng Sci. 11, 482-490.

A. Noorlidah, I. Rozila, M. Norjuliz, M. Annuar (2013) Production of liquid spawn of an edible grey oyster mushroom, Pleurotus pulmonarius (Fr.) Quél by submerged cultivation and sporophore yield on rubber wood sawdust, Scientia Horticulturae. 161, 65-69.

M. Berovič, M. Knežević (1995) Pleurotus saca submerged cultivation. 17(8), 839-844.

Lefki-Maria Papaspyridi, Petros Katapodis, Zacharoula Gonou-Zagou, Evangelia Kapsanaki-Gotsi, Paul Christakopoulos (2010) Optimization of biomass production with enhanced glucan and dietary fibres content by Pleurotus ostreatus ATHUM 4438 under submerged culture, Biochemical Engineering Journal 2010. 50(3), 131-138. https://doi.org/10.1016/j.bej.2010.04.008

Lefki-Maria Papaspyridi, Nektarios Aligiannis, Paul Christakopoulos, Alexios-Leandros Skaltsounis, Nikolas Fokialakis (2011) Production of bioactive metabolites with pharmaceutical and nutraceutical interest by submerged fermentation of Pleurotus ostreatus in a batch stirred tank bioreactor. 1, 1746-1752. https://doi.org/10.1016/j.profoo.2011.09.257

X. Wang, Z. Ding, Y. Zhao, G. Liu, G. Zhou Efficient Accumulation and In-Vitro Antitumor Activities of Triterpene Acids from Fed-Batch Cultivation of Ling-Zhi or Reishi Medical Mushroom Ganoderma lucidum (Agaricomycetes).

H. Shi, M. Zhang, S. Devahastin New development of efficient processing techniques on typical medicinal fungi: A Review.

R. Hatti-Kaul, B. Mattiasson (2003) Hatti-Kaul, R.; Mattiasson, B.

A. Middelberg (1995) Process-scale disruption of microorganisms. 13, 491-504.

Y. Xiao, A. Qiang, W. Lian, F. Yiang, J. Sun, S. Guo (2009) Qiang, A.; Lian, W.Y.; Yiang F.Y.; Sun, J.C.; Guo, S.G Application of superfine pulverization technology in biomaterial industry J Taiwan Institute Chem E. 40, 337-343.

Ulrike Lindequist, Timo Niedermeyer, Wolf-Dieter Jülich (2005) The pharmacological potential of mushrooms Evid Based Complement Alternat Med. 2(3), 285-299. https://doi.org/10.1093/ecam/neh107

H. Luo, Y. Li (2023) Down Stream Processing of Medicinal Mushrooms Products.

Medicinal Mushroom Biotechnology

Published

2024-05-13

How to Cite

Medicinal Mushroom Biotechnology. (2024). Global Journal of Science Frontier Research, 24(7), 35-51. https://www.journalofscience.org/index.php/GJSFR/article/view/102879